Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020
Published: Jan-2014    |    Formats: PDF & Excel   |   Author(s):Debbie Shields and Rohini Patil   |   Code: ME 14124
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology
  • Analyst's
    Review
  • Sample

Pages 106
Tables 50

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.  Other driving factors of the IVF market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.

The major limiting factor of this market is the cost involved in the treatment. The patient may not conceive in the first cycle of IVF procedure. Many cycles have to be undergone by the patient to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $10,000-$20,000. This acts as a major limitation in adoption of the technique for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria. Awareness can be created through medical tourism and availability of low cost IVF treatments.

The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ova Science.

Infertile Couples and Investors, both can capitalized form Global IVF market

KEY BENEFITS

  • In-depth analysis of the IVF market, segmented based on instruments, reagents and media, technology, end users and geographies
  • Quantitative analysis of the current market and estimations through 2013-2020   
  • Assessment and ranking of the factors affecting the global market and impact analysis of the same  
  • Identification of key investment pockets in the market, which would assist companies to take profitable investment decisions
  • Study of the bargaining power of buyers and suppliers in the market, based on porter’s five force analysis
  • Understanding the key intermediaries in the market based on value chain analysis
  • Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
  • SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions

KEY AUDIENCES

  • Hospitals
  • Fertility clinics
  • Instruments and reagent manufacturers
  • Cryopreservation banks
  • Government and private institutes

CHAPTER 1 INTRODUCTION

1.1 Key Benefits
1.2 Key Audiences
1.3 Research Methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL IVF MARKET OVERVIEW

3.1 Market definition and scope
3.2 Alternative technologies

3.2.1 IUI technique

3.2.1.1 Factors assessed for the procedure
3.2.1.2 Reasons for use of the technique
3.2.1.3 Benefits of this technique
3.2.1.4 Risks

3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique

3.2.3.1 Difference between GIFT and IVF technique

3.2.4 ZIFT technique

3.2.4.1 Differences between ZIFT and IVF technique

3.3 Replacing IVF procedures by fertility drugs and surgeries

3.3.1 Female infertility treatments

3.3.1.1 Limitations of fertility drugs

3.3.2 Male infertility treatments

3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market

3.5.1 Egg donation

3.5.1.1 Egg sharing

3.5.2 Sperm donation
3.5.3 Embryo donation
3.5.4 Donation for research

3.6 Surrogacy

3.6.1 Legal issues

3.7 Rise in same sex couples

3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization

3.8 Advanced technologies in IVF

3.8.1 Capsule IVF
3.8.2 Three parent IVF

3.8.2.1 Ethical concerns

3.8.3 Mini IVF

3.8.3.1 Advantages
3.8.3.2 Drawbacks

3.8.4 EmbryoScope

3.8.4.1 Advantages

3.8.5 PICSI

3.9 Fertility treatment and Gender selection

3.9.1 Methods of sex selection

3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues

3.10 Metabolomics in embryo screening methods

3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Top ten factors impacting IVF market
3.14 Top winning strategies in the IVF market
3.15 Porter’s five forces analysis

3.15.1 Competition declining suppliers power
3.15.2 Availability of options impacting buyer power
3.15.3 High cost -a hindrance to new entrants
3.15.4 Application of strategies to overcome competition
3.15.5 Inefficient threat from substitutes

3.16 Value chain analysis
3.17 Insurance reimbursement Scenario
3.18 Regulatory issues and legislations
3.19 Clinical trials

3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures

3.20 Market dynamics

3.20.1 Drivers

3.20.1.1 Age
3.20.1.2 Rise in infertility rates
3.20.1.3 Advancement in technology
3.20.1.4 Rise in donation
3.20.1.5 Increase in average income
3.20.1.6 Increase in success rates

3.20.2 Restraints

3.20.2.1 Physical and emotional impact
3.20.2.2 Ethical and legal issues
3.20.2.3 Cost of the treatment
3.20.2.4 Multiple pregnancies
3.20.2.5 Low awareness level

3.20.3 Opportunities:

3.20.3.1 Medical tourism
3.20.3.2 New technology trends
3.20.3.3 Rise in same sex marriages

CHAPTER 4 GLOBAL IVF MARKET BY INSTRUMENTS

4.1 Global IVF market by instruments types, 2012-2020,$million
4.2 Global IVF instruments market, by geography, 2012-2020, $million
4.3 Incubators

4.3.1 Global IVF incubators market , by geography, 2012-2020, $million

4.4 Cryosystem

4.4.1 Global IVF cryosystem market, by geography, 2012-2020, $million

4.5 Imaging system

4.5.1 Global IVF Imaging system market , by geography, 2012-2020, $million

4.6 Cabinet( work station)

4.6.1 Global IVF cabinets market , by geography, 2012-2020, $million

4.7 Ovum Aspiration pump

4.7.1 Global IVF ovum aspiration pump market , by geography, 2012-2020, $million

4.8 Sperm separation system

4.8.1 Global IVF Sperm seperation system market, by geography, 2012-2020, $million

4.9 Accessories and disposables

4.9.1 Semen analysis chamber
4.9.2 Plastic ware
4.9.3 Oocyte retrieval needles
4.9.4 Miscellaneous disposables
4.9.5 Global IVF accessories and disposable market , by geography, 2012-2020, $million

4.10 Micro Manipulator System

4.10.1 Global IVF Micromanipulator market , by geography, 2012-2020, $million

4.11 Others

4.11.1 Refrigerators

4.11.1.1 Global IVF other instruments market , by geography, 2012-2020, $million

CHAPTER 5 GLOBAL IVF MARKET BY REAGENTS AND MEDIA

5.1 Global IVF market by reagents and media types,2012-2020,$million
5.2 Global IVF reagents and media market, by geography, 2012-2020, $million
5.3 Cryopreservation media

5.3.1 Embryo cryopreservation media
5.3.2 Sperm cryopreservation media
5.3.3 Oocyte cryopreservation media

5.3.3.1 Disadvantage
5.3.3.2 Advantages

5.3.4 Global IVF cryopreservation media market , by geography, 2012-2020, $million

5.4 Semen processing media

5.4.1 Global IVF semen processing media market , by geography, 2012-2020, $million

5.5 Ovum processing media

5.5.1 Global IVF ovum processing media market , by geography, 2012-2020, $million

5.6 Embryo culture media

5.6.1 Global IVF embryo culture media market , by geography, 2012-2020, $million

CHAPTER 6 GLOBAL IVF MARKET BY TECHNOLOGY

6.1 Global IVF market, by technology, 2012-2020, $million
6.2 Global IVF technology market, by geography, 2012-2020, $million
6.3 PGD technique

6.3.1 Drivers
6.3.2 Restraints
6.3.3 Global IVF pre-implantation genetic diagnosis market , by geography, 2012-2020, $million

6.4 FER technique

6.4.1 Reasons to use this technique
6.4.2 Advantages of FER technique
6.4.3 Disadvantages of FER technique

6.4.4 Global IVF Frozen embryo replacement market , by geography, 2012-2020, $million

6.5 ICSI Technique

6.5.1 Benefits
6.5.2 Risks
6.5.3 Global IVF intra cytoplasmic sperm injection market , by geography, 2012-2020, $million

6.6 Others:

6.6.1 Global IVF other technology market , by geography, 2012-2020, $million
6.6.2 IVM Technique
6.6.3 Assisted hatching

CHAPTER 7 GLOBAL IVF MARKET BY END USERS

7.1 Global IVF market by end users, 2012-2020, $million
7.2 Global IVF end use market, by geography, 2012-2020, $million
7.3 Hospitals

7.3.1 Global IVF Hospitals market , by geography, 2012-2020, $million

7.4 Clinics

7.4.1 Global IVF Clinics market , by geography, 2012-2020, $million

7.5 Surgical centers

7.5.1 Global IVF Surgical centers market , by geography, 2012-2020, $million

7.6 Clinical research institutes

7.6.1 Global IVF clinical research institutes market , by geography, 2012-2020, $million

7.7 Banks

7.7.1 Global IVF banks market , by geography, 2012-2020, $million

CHAPTER 8 IVF MARKET BY GEOGRAPHY

8.1 Europe
8.2 North America

8.2.1 North American IVF market, 2012-2020, $million

8.3 Asia pacific

8.3.1 Asia Pacific IVF market, 2012-2020, $million

8.4 RoW

8.4.1 RoW IVF market, 2012-2020, $million

CHAPTER 9 COMPANY PROFILES

9.1 Vitrolife AB

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Strategic moves and developments

9.1.4.1 Primary strategies: regulatory approvals, acquisition and agreements
9.1.4.2 Others

9.1.5 SWOT Analysis of Vitrolife AB

9.2 EMD Serono, Inc

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Strategic moves and developments

9.2.4.1 Primary strategies

9.2.5 SWOT Analysis of EMD Serono, Inc

9.3 Irvine scientific

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Strategic moves and developments

9.3.4.1 Primary strategy: FDA approvals

9.3.5 SWOT Analysis of Irvine scientific

9.4 Cooper Surgical, Inc.

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Strategic moves and developments

9.4.4.1 Primary strategies

9.4.5 SWOT Analysis of Cooper Surgical, Inc

9.5 Cook Medical, Inc

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Strategic moves and developments

9.5.3.1 Primary strategies

9.5.4 SWOT Analysis of Cook medical

9.6 Thermo Fisher Scientific Inc.

9.6.1 Company overview:
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments

9.6.4.1 Primary strategy: product launch

9.6.5 SWOT Analysis of Thermo Fisher Scientific Inc.

9.7 Genea Biomedx

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments

9.7.3.1 Primary strategy: product launch

9.7.4 SWOT Analysis of Genea Biomedx

9.8 Auxogyn, Inc

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Strategic moves and developments

9.8.3.1 Primary strategies- Agreement and partnership
9.8.3.2 Others strategies

9.8.4 SWOT Analysis of Auxogyn, Inc

9.9 Oxford Gene Technology

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments

9.9.3.1 Primary strategy: product launch

9.9.4 SWOT analysis of oxford gene technology

9.10 Ovascience

9.10.1 Company overview
9.10.2 Business Performance
9.10.3 Strategic moves and developments

9.10.3.1 Primary strategy

9.10.4 SWOT analysis of Ovascience

 

LIST OF TABLES:

TABLE 1  GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 2  INSURANCE COVERAGE FOR COUNTRIES
TABLE 3  GLOBAL IVF MARKET BY INSTRUMENTS TYPES,2012-2020,$MILLION
TABLE 4  GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 5  GLOBAL IVF INCUBATORS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 6  GLOBAL IVF CRYOSYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 7  GLOBAL IVF IMAGING SYSTEM MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 8  GLOBAL IVF CABINETS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 9  GLOBAL IVF OVUM APIRATION PUMP MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 10  GLOBAL IVF SPERM SEPERATION SYSTEM MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 11  GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 12  GLOBAL IVF MICROMANIPULATOR MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 13  GLOBAL IVF OTHER INSTRUMENTS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 14  GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES,2012-2020,$MILLION
TABLE 15  GLOBAL IVF REAGENTS AND MEDIA MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 16  CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 17  GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 18  GLOBAL IVF SEMEN PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 19  GLOBAL IVF OVUM PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 20  EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 22  GLOBAL IVF EMBRYO CULTURE MEDIA MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 23  GLOBAL IVF MARKET, BY TECHNOLOGY, 2012-2020, $MILLION
TABLE 24  GLOBAL IVF TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 25  GLOBAL IVF PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 26  GLOBAL IVF FROZEN EMBRYO REPLACEMENT MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 27  GLOBAL IVF INTRA CYTOPLASMIC SPERM INJECTION MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 28  GLOBAL IVF OTHER TECHNOLOGY MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 29  GLOBAL IVF MARKET BY END USERS,2012-2020,$MILLION
TABLE 30  GLOBAL IVF END USER MARKET, BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 31  GLOBAL IVF HOSPITALS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 32  GLOBAL IVF CLINICS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 33  GLOBAL IVF SURGICAL CENTERS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 34  GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 35  GLOBAL IVF BANKS MARKET , BY GEOGRAPHY, 2012-2020, $MILLION
TABLE 36  EUROPE’S ACTIVE COUNTRIES FOR IVF TREATMENT, 2010
TABLE 37  EMEA IVF MARKET, 2012-2020, $MILLION
TABLE 38  NORTH AMERICAN IVF MARKET, 2012-2020, $MILLION
TABLE 39  ASIA PACIFIC IVF MARKET, 2012-2020, $MILLION
TABLE 40  ROW IVF MARKET, 2012-2020, $MILLION
TABLE 41  SNAP SHOT OF VITROLIFE AB
TABLE 42  SNAP SHOT OF EMD SERONO, INC
TABLE 43  SNAP SHOT OF IRVINE SCIENTIFIC
TABLE 44  SNAP SHOT OF COOPER SURGICAL, INC
TABLE 45  SNAP SHOT OF COOK MEDICAL
TABLE 46  SNAP SHOT OF THERMO FISHER SCIENTIFIC INC
TABLE 47  SNAP SHOT OF GENEA BIOMEDX
TABLE 48  SNAP SHOT OF AUXOGYN, INC
TABLE 49  SNAP SHOT OF OXFORD GENE TECHNOLOGY
TABLE 50  SNAP SHOT OF OVASCIENCE

 

LIST OF FIGURES:

FIG. 1  IUI SUCCESS RATES BY AGE UK, 2010
FIG. 2  HIGH ORDER BIRTH RATES: MEDICALLY ASSISTED VS IVF TECHNIQUE
FIG. 3  COST OF BASIC IVF TYPE PROCEDURES
FIG. 4  PERCENTAGE OF LIVE BIRTH USING DONOR EGGS, U.S.A, 2011
FIG. 5  LIVE BIRTH RATE PER CYCLE USING DONOR SPERM, U.K. 2010
FIG. 6  EMBRYOS CREATED USING DONOR EGGS, EUROPE
FIG. 7  ADOPTION RATE BY TYPE OF SURROGACY
FIG. 8  TOP FACTORS IMPACTING IVF MARKET (2013-2020)
FIG. 9  TOP WINNING STRATEGIES OF IVF MARKET (2010-2013)
FIG. 10  PORTER’S FIVE FORCE ANALYSIS:
FIG. 11  VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 12  EFFECT OF AGE ON FERTILITY
FIG. 13  COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 14  SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE ,2011,U.S.A
FIG. 15  PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2011 (USA)
FIG. 16  LIVE BIRTH RATE PER CYCLE, AFTER FROZEN EMBRYO TRANSFER, 2011(USA)
FIG. 17  PERCENTAGES OF COUPLES SEEKING ICSI TREATMENT, BY THE REASON THEY SOUGHT TREATMENT, U.S.A ,2011
FIG. 18  PERCENTAGE OF CYCLES RESULTING IN LIVE BIRTHS (2010) U.K
FIG. 19  POLICIES PROVIDED BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
FIG. 20  SALES PER REGION 2012
FIG. 21  SWOT ANALYSIS OF VITROLIFE AB
FIG. 22  SALES BY REGION, 2012
FIG. 23  SWOT ANALYSIS OF EMD SERONO, INC
FIG. 24  SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 25  SWOT ANALYSIS OF COOPER SURGICAL, INC
FIG. 26  SWOT ANALYSIS OF COOK MEDICAL
FIG. 27  FINANCIAL REVENUES BY BUSINESS UNITS (2012)
FIG. 28  FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 29  SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.
FIG. 30  SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 31  SWOT ANALYSIS OF AUXOGYN, INC
FIG. 32  SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 33  SWOT ANALYSIS OF OVASCIENCE

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

The IVF market analyzed in this report includes the various technologies of in-vitro fertilization along with the instruments, reagents and media used during the procedures. The market is segmented into instruments, reagents and media, technology and end users. This report excludes the in depth analysis of IVF in the service market and drugs market.

The scope of the market in the upcoming years is increase in technological advancement, high success rates, cost efficient treatments, and uncomplicated procedures that would save both the patients as well as the doctor’s time.

This market has growth opportunities in the geographic areas such as Asia pacific and RoW, where the rate of infertility is increasing and need for better IVF techniques that are cost efficient.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

SIMILAR MARKET STUDIES

Published Reports

Catheters are thin tubes made up of medical grade material such as plastic, silicon rubber, PVC and nylon that are inserted in the patient’s body for therapeutic and diagnostic purposes. Catheterization is a primary co-procedure along with varied other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery among others. Catheters are the vital component in several surgical procedures.
11 Nov 2014 | Price: $4515(SU) | View Details >>

Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global bio implants market is forecast to reach $115.8 billion by 2020, registering a CAGR of 10.3% from 2014 to 2020.
23 Oct 2014 | Price: $4515(SU) | View Details >>

Sexually Transmitted Diseases (STDs) are also known as Venereal diseases (VDs) or Sexually Transmitted Infections (STIs). A variety of methods have been employed for diagnosis of STDs that differ based on the type of disease. The objective of this report is to provide an in-depth understanding of diagnostic tests of STDs. The market diagnostic testing of STDs was valued at $96.7 billion in 2013 with a corresponding test volume of 4,204 million.
10 Nov 2014 | Price: $4515(SU) | View Details >>

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
3 Jun 2014 | Price: $4515(SU) | View Details >>

Disposable gloves are primarily used across health care and food industry, as a protection tool in order to avoid cross- infection between caregivers and patients. Over time, various variants of disposable gloves have been developed such as natural rubber, nitrile, vinyl and neoprene. Each of the variants renders unique benefits over conventional gloves; this renders wide application over a range of industries such as food service, clean room, industrial application among others. For instance, nitrile gloves are more puncture resistant, friction less, with long shelf life than latex gloves.
16 Oct 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Particle size analysis is an analytical technique through which samples containing particulate material is distributed, measured and reported. This particulate material present could be in solid or liquid form. It is essential to analyze the particle’s size as it affects the material’s functioning. Increasing adoption of particle size analyzers in nanotechnology is contributing tothe growth of this market
Price: $4515 | Pre Book Price: $4515 | View Details >>

The safety of patientsand operators is a primary concern when it comes to medical power supply.Advances in technology and innovation are significantly impacting the medical power supply market.The growing demand for medical equipment which is smaller, more efficient, more cost-effective, reliable, and lighter is also affecting market growth.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Infusion pumps are medical devices that are used to deliver fluids, nutrients or medications (such as insulin and other hormones, chemotherapy drugs, antibiotics and pain relievers) into a patients body in a controlled manner. A number of infusion pumps are available for different applications.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Memory devices are the implantable devices designed to control the voluntary activities of brain or neuron in people who suffer from brain damage due to stroke, Alzheimers, and disruption of neural network due to chronic brain damage.
Price: $4515 | Pre Book Price: $4515 | View Details >>

Vital signs, such as breathing rate, temperature, heartbeat and blood pressure are essential in measuring, monitoring and keeping a watch on basic body functioning. Vital signs devices thus play an important role in maintaining health as they monitor various vital parameters. The vital signs monitoring market comprises of services and devices for emergency care and support. The inclination of patients towards treatment at home as opposed to hospitals in order to cut costs is a significant trend witnessed in this market
Price: $4515 | Pre Book Price: $4515 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Get Discount

NEED MORE INFORMATION?
Call
+1 617 674 4143


Purchase Enquiry

PURCHASE OPTIONS

Single User
By obtaining a Single User License, you and your organization concur that only an individual uses this report either electronically or online. The right to use or stockpiling of the report should be confined only to one authorized computer. User will have authorization to print one duplicate of the report for individual use, yet may not be replicated for circulation. Additional copies for this report may also be order at discounted price for use by addition readers/users.
$4515

Multi User 
Multi-User license permits you to access the report from eight authorized computers. It does not permit you to display it on your company website and permits you to only print 5 copies of the report that shall not be reproduced for circulation.
$7515

Corporate  
With corporate use license, the complete or part of the content of the report can be shared or made available to other persons, other divisions and subsidiaries of same company. However, reproduction or redistribution of the report in is prohibited without the prior permission of Allied Market Research. The publisher will, in turn, regard the privacy of the purchaser and will keep it confidential. Upon buying single or multi-user license, buyer must provide the names and email ids of the authorized users of this report.
$10515


Not Interested in buying complete report?
To check the cost of chapters
WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top